Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Mao

Showing results (521-530 of 540) with videos related to

Pageof 54
Sort By:
International Journal of Molecular Sciences|June 26, 2026
Integrated Metabolomics and Transcriptomics Analysis of Exogenous Arginine-Mediated Sucrose Accumulation in SugarcaneHong-Bo Liu, Tanweer Kumar, Xiu-Qin Lin, et al.
Cell Genomics|October 10, 2024
A genome-wide association study of neonatal metabolitesQuanze He, Hankui Liu, Lu Lu, et al.
Journal of Pain and Symptom Management|September 28, 2023
Challenges in Implementing Guideline on Integrative Oncology and Pain: The Israeli PerspectiveEran Ben-Arye, Jun Mao, Eduardo Bruera, et al.
Nature Communications|August 20, 2025
Miniaturized Mg<sub>3</sub>Bi<sub>2</sub>-based thermoelectric cooler for localized electronic thermal managementChenhao Lin, Xiaojing Ma, Kun Liang, et al.
Scientific Reports|January 13, 2021
Human whole genome sequencing in South AfricaBrigitte Glanzmann, Tracey Jooste, Samira Ghoor, et al.
Nature Communications|May 6, 2026
Minimal twin structures enabling extraordinary thermoelectric power factor of n-type Bi<sub>2</sub>Te<sub>3</sub> thin filmsHaoran Ge, Rui Cheng, Wei Liu, et al.
Nature Communications|October 26, 2023
Edge-rich molybdenum disulfide tailors carbon-chain growth for selective hydrogenation of carbon monoxide to higher alcoholsJingting Hu, Zeyu Wei, Yunlong Zhang, et al.
Nature Communications|January 19, 2019
Discovery of TaFeSb-based half-Heuslers with high thermoelectric performanceHangtian Zhu, Jun Mao, Yuwei Li, et al.
Nature Communications|March 5, 2022
A programmable qudit-based quantum processorYulin Chi, Jieshan Huang, Zhanchuan Zhang, et al.
World Journal of Gastrointestinal Oncology|September 2, 2022
Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinomaXi Wang, Cheng-Sheng Zhang, Xu-Yuan Dong, et al.
Pageof 54

Showing results (521-530 of 540) with videos related to

Sort By:
Pageof 54
International Journal of Molecular Sciences|June 26, 2026
Integrated Metabolomics and Transcriptomics Analysis of Exogenous Arginine-Mediated Sucrose Accumulation in SugarcaneHong-Bo Liu, Tanweer Kumar, Xiu-Qin Lin, et al.
Cell Genomics|October 10, 2024
A genome-wide association study of neonatal metabolitesQuanze He, Hankui Liu, Lu Lu, et al.
Journal of Pain and Symptom Management|September 28, 2023
Challenges in Implementing Guideline on Integrative Oncology and Pain: The Israeli PerspectiveEran Ben-Arye, Jun Mao, Eduardo Bruera, et al.
Nature Communications|August 20, 2025
Miniaturized Mg<sub>3</sub>Bi<sub>2</sub>-based thermoelectric cooler for localized electronic thermal managementChenhao Lin, Xiaojing Ma, Kun Liang, et al.
Scientific Reports|January 13, 2021
Human whole genome sequencing in South AfricaBrigitte Glanzmann, Tracey Jooste, Samira Ghoor, et al.
Nature Communications|May 6, 2026
Minimal twin structures enabling extraordinary thermoelectric power factor of n-type Bi<sub>2</sub>Te<sub>3</sub> thin filmsHaoran Ge, Rui Cheng, Wei Liu, et al.
Nature Communications|October 26, 2023
Edge-rich molybdenum disulfide tailors carbon-chain growth for selective hydrogenation of carbon monoxide to higher alcoholsJingting Hu, Zeyu Wei, Yunlong Zhang, et al.
Nature Communications|January 19, 2019
Discovery of TaFeSb-based half-Heuslers with high thermoelectric performanceHangtian Zhu, Jun Mao, Yuwei Li, et al.
Nature Communications|March 5, 2022
A programmable qudit-based quantum processorYulin Chi, Jieshan Huang, Zhanchuan Zhang, et al.
World Journal of Gastrointestinal Oncology|September 2, 2022
Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinomaXi Wang, Cheng-Sheng Zhang, Xu-Yuan Dong, et al.
Pageof 54